Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages
- PMID: 21998409
- PMCID: PMC3269210
- DOI: 10.1126/scitranslmed.3003045
Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages
Abstract
Control of tuberculosis worldwide depends on our understanding of human immune mechanisms, which combat the infection. Acquired T cell responses are critical for host defense against microbial pathogens, yet the mechanisms by which they act in humans remain unclear. We report that T cells, by the release of interferon-γ (IFN-γ), induce autophagy, phagosomal maturation, the production of antimicrobial peptides such as cathelicidin, and antimicrobial activity against Mycobacterium tuberculosis in human macrophages via a vitamin D-dependent pathway. IFN-γ induced the antimicrobial pathway in human macrophages cultured in vitamin D-sufficient sera, but not in sera from African-Americans that have lower amounts of vitamin D and who are more susceptible to tuberculosis. In vitro supplementation of vitamin D-deficient serum with 25-hydroxyvitamin D3 restored IFN-γ-induced antimicrobial peptide expression, autophagy, phagosome-lysosome fusion, and antimicrobial activity. These results suggest a mechanism in which vitamin D is required for acquired immunity to overcome the ability of intracellular pathogens to evade macrophage-mediated antimicrobial responses. The present findings underscore the importance of adequate amounts of vitamin D in all human populations for sustaining both innate and acquired immunity against infection.
Figures
Comment in
-
Infectious disease: a ray of sunshine for TB treatment.Nat Rev Immunol. 2011 Nov 4;11(12):802. doi: 10.1038/nri3110. Nat Rev Immunol. 2011. PMID: 22051891 No abstract available.
References
-
- World Health Organization. Geneva: World Health Organization; 2009. Tuberculosis Facts, 2009 Update. http://www.who.int/tb/publications/2009/factsheet_tb_2009update_dec09.pdf.
-
- Havlir DV, Barnes PF. Tuberculosis in patients with human immunodeficiency virus infection. N. Engl. J. Med. 1999;340:367–373. - PubMed
-
- Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M. A mutation in the interferon-γ–receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 1996;335:1941–1949. - PubMed
-
- Jouanguy E, Lamhamedi-Cherradi S, Lammas D, Dorman SE, Fondaneche MC, Dupuis S, Döffinger R, Altare F, Girdlestone J, Emile JF, Ducoulombier H, Edgar D, Clarke J, Oxelius VA, Brai M, Novelli V, Heyne K, Fischer A, Holland SM, Kumararatne DS, Schreiber RD, Casanova JL. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet. 1999;21:370–378. - PubMed
-
- Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, Drysdale P, Jouanguy E, Döffinger R, Bernaudin F, Jeppsson O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumararatne D, Casanova JL. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science. 1998;280:1432–1435. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
